cefepime + enmetazobactam
Commercial- Indications
- Complicated urinary tract infections
Company intelligence / Profile preview
Allecra Therapeutics
Weil am Rhein, Baden-Württemberg, Germanyallecra.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Commercial
01
Overview
Lead product candidate cefepime/enmetazobactam has shown superiority over standard of care in patients with complicated urinary tract infections (cUTIs) in a randomized, controlled, double-blind, global Phase 3 trial. The company is preparing submissions for marketing approval in the U.S. and EU based on these results[3][6][7].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Antibioticssmall molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Shanghai Haini Pharmaceutical (exclusive licensing agreement for Greater China)Orchid Chemicals & Pharmaceuticals LimitedAcino (exclusive licensing and supply agreement for Gulf Cooperation Council countries and South Africa)
Beyond the preview
Go deeper on Allecra Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allecra Therapeutics.